Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017193-20Phase 4Completed
Phase 4 trial of naloxone and methylnaltrexone, sponsored by UZ Leuven. Primary endpoint: liquid nutrient tolerance to reach maximum satiation. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017193-20.